Keybanc upgraded GDRX to "overweight" from "sector weight"
GoodRx Holdings Inc (NASDAQ:GDRX) stock is up 1.9% to trade at $6.87 this morning, after Keybanc upgraded the digital healthcare service to "overweight" from "sector weight," while setting a price target of $9. The analyst in coverage cited the potential for strong subscriber growth, as well as a positive shift in the company's monthly active users (MAUs).
GoodRx jumped nearly 4% premarket, but broad market headwinds are capping gains. The stock has support at its 80-day moving average, which has propped up the consolidation since an early-January bull gap. Year over year, the equity is up 17%.
There is still plenty of pessimism surrounding the stock. Factoring in today's bull note, 11 of the 20 analysts in coverage still carry a "hold" or worse rating on GDRX. Plus, short interest represents 12.5% of the stock's available float, and would take nearly six days to cover at the security's average pace of trading.